$3.79
0.020.53%
Last update: 11:29 AM
15 minutes delayed
Metagenomi
MGXNASDAQ
Metagenomi (NASDAQ:MGX) Stock, Analyst Ratings, Price Targets, Predictions
Metagenomi Inc has a consensus price target of $15.29, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and JP Morgan on May 15, 2024, May 7, 2024, and May 2, 2024. With an average price target of $8.67 between HC Wainwright & Co., HC Wainwright & Co., and JP Morgan, there's an implied 128.67% upside for Metagenomi Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JP Morgan
Chardan Capital
BMO Capital
TD Cowen
1calculated from analyst ratings
Analyst Ratings for Metagenomi
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/15/2024 | Buy Now | 163.85% | HC Wainwright & Co. | Mitchell Kapoor | → $10 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 163.85% | HC Wainwright & Co. | Mitchell Kapoor | → $10 | Initiates | → Buy | Get Alert |
| 05/02/2024 | Buy Now | 58.31% | JP Morgan | Brian Cheng | $16 → $6 | Downgrade | Overweight → Neutral | Get Alert |
| 03/28/2024 | Buy Now | 454.09% | Chardan Capital | Geulah Livshits | $21 → $21 | Maintains | Buy | Get Alert |
| 03/05/2024 | Buy Now | 480.47% | BMO Capital | Kostas Biliouris | → $22 | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | — | TD Cowen | Joseph Thome | — | Initiates | → Outperform | Get Alert |
| 03/05/2024 | Buy Now | 559.63% | Wells Fargo | Yanan Zhu | → $25 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 322.16% | JP Morgan | Brian Cheng | → $16 | Initiates | → Overweight | Get Alert |
| 03/05/2024 | Buy Now | 506.86% | Jefferies | Maury Raycroft | → $23 | Initiates | → Buy | Get Alert |
| 03/05/2024 | Buy Now | 454.09% | Chardan Capital | Geulah Livshits | → $21 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Metagenomi (MGX) stock?
The latest price target for Metagenomi (NASDAQ:MGX) was reported by HC Wainwright & Co. on May 15, 2024. The analyst firm set a price target for $10.00 expecting MGX to rise to within 12 months (a possible 163.85% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Metagenomi (MGX)?
The latest analyst rating for Metagenomi (NASDAQ:MGX) was provided by HC Wainwright & Co., and Metagenomi reiterated their buy rating.
When was the last upgrade for Metagenomi (MGX)?
There is no last upgrade for Metagenomi
When was the last downgrade for Metagenomi (MGX)?
The last downgrade for Metagenomi Inc happened on May 2, 2024 when JP Morgan changed their price target from $16 to $6 for Metagenomi Inc.
When is the next analyst rating going to be posted or updated for Metagenomi (MGX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Metagenomi, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Metagenomi was filed on May 15, 2024 so you should expect the next rating to be made available sometime around May 15, 2025.
Is the Analyst Rating Metagenomi (MGX) correct?
While ratings are subjective and will change, the latest Metagenomi (MGX) rating was a reiterated with a price target of $10.00 to $10.00. The current price Metagenomi (MGX) is trading at is $3.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.